Cardiac shock wave therapy (CSWT) for non-invasive treatment of ischaemic heart diseases such as angina pectoris

Among cardiovascular diseases, ischaemic heart disease is the most common cause of death in industrialized nations. Although medication or interventional procedures provide good results in the treatment of systolic heart failure, these therapies are not suitable for all affected patients due to the extra strain they put on the body. When treating diastolic heart failure, in particular, the medication and therapies available today are ineffective.

Non-invasive cardiac shock wave therapy performed on an outpatient basis provides a significant improvement of angina pectoris (graded according to the NYHA and CCS classification) while at the same time increasing physical performance capability1. Being a gentle treatment method with hardly any complications, CSWT can also be performed on risk patients to improve their quality of life (assessed through the SAQ) in the long term (results obtained over a 6-years follow-up period2).


System control and convenience

The MODULITH® SLC can be used with different patient tables. Alignment of the individual system components is accomplished by motorized movement of the therapy source.

The graphical user interface enables the operator to view and check all major system functions and status messages at a glance. A simple touch of a finger is needed to select preconfigured parking and therapy positions. This saves valuable time during treatment preparation.

A 3D joystick mounted to the gel bottle holder of the ultrasound system is provided as an additional control option. This enables ergonomic localization of the target area while keeping everything under control.


Electromagnetic cylindrical source

The proven shock wave technology developed by STORZ MEDICAL makes use of a cylindrical coil in combination with a parabolic reflector for focusing.

The cylindrical design of the STORZ MEDICAL therapy coil enables convenient installation of the ultrasound transducer in the centre of the therapy head. As a result, the myocardium shown in the ultrasound image is displayed on the central therapy head axis.

In-line localization ensures that obstacles such as ribs are instantly visible in the ultrasound image and that sensitive regions such as the lungs can be reliably identified. Thanks to the unrestricted 360° rotation capability of the guide axis, the ultrasound transducer position can be perfectly adjusted to the intercostal sound window to ensure ideal imaging of the target area.


1Clinical Effect of Cardiac Shock Wave Therapy on Myocardial Ischemia in Patients With Ischemic Heart Failure
Wenxia Wang, MS1, Hua Liu, PhD1, Mengxian Song, BS1, Weiyi Fang, PhD1, and Fang Yuan, MS1

2Cardiac shock wave therapy shows better outcomes in the coronary artery disease patients in a long term
S. Nirala, Y. Wang, Y.-Z. Peng, P. Yang, T. Guo


I am interested in the MODULITH® SLC.

Please contact me at:

I consent that STORZ MEDICAL AG, Lohstampfestrasse 8, 8274 Tägerwilen, Switzerland, and the distributors of STORZ MEDICAL AG may process my previously provided personal data for the purposes of market research, advertising and analysis and may contact me for these purposes by post, e-mail, messenger service, telephone or SMS in order to inform me about current offers and services relating to medical products of STORZ MEDICAL AG in the fields of urology, orthopaedics, cardiology, aesthetics, neurology and veterinary medicine. I can revoke this consent at any time – also partially – vis-à-vis STORZ MEDICAL AG or the distributor responsible for me (in particular via ).

Linkedin Channel Facebook Channel Instagram Channel Twitter Youtube Channel